Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,553 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $389.50 | 6 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $248.02 | 2 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $200.00 | 2 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $125.00 | 1 | $0 (2019) |
| Allergan Inc. | $121.93 | 2 | $0 (2018) |
| PFIZER INC. | $99.50 | 1 | $0 (2018) |
| Mitsubishi Tanabe Pharma America, Inc. | $95.65 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $77.91 | 1 | $0 (2019) |
| Bard Peripheral Vascular, Inc. | $71.21 | 1 | $0 (2022) |
| PFIZER PHARMACEUTICALS LLC | $70.62 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $124.99 | 1 | AstraZeneca Pharmaceuticals LP ($124.99) |
| 2022 | $71.21 | 1 | Bard Peripheral Vascular, Inc. ($71.21) |
| 2021 | $123.03 | 1 | AstraZeneca Pharmaceuticals LP ($123.03) |
| 2020 | $19.99 | 1 | Janssen Pharmaceuticals, Inc ($19.99) |
| 2019 | $686.76 | 10 | Janssen Pharmaceuticals, Inc ($219.51) |
| 2018 | $340.13 | 5 | Janssen Pharmaceuticals, Inc ($100.00) |
| 2017 | $186.45 | 4 | Allergan Inc. ($103.60) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/13/2022 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $71.21 | General |
| Category: BD Interventional Peripheral Intervention | ||||||
| 11/03/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/13/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: DIABETES | ||||||
| 10/24/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/19/2019 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ORTHOPEDICS | ||||||
| 08/27/2019 | Janssen Pharmaceuticals, Inc | INVOKAMET (Drug), INVOKANA | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $77.91 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/17/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Endocrinology | ||||||
| 05/03/2019 | PTC Therapeutics, Inc. | EMFLAZA (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: DMD | ||||||
| 04/11/2019 | PFIZER PHARMACEUTICALS LLC | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $29.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/14/2019 | Mitsubishi Tanabe Pharma America, Inc. | Radicava (Drug) | Food and Beverage | In-kind items and services | $95.65 | General |
| Category: Amyotrophic Lateral Sclerosis | ||||||
| 10/03/2018 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: DIABETES | ||||||
| 04/26/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $99.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/20/2018 | PFIZER PHARMACEUTICALS LLC | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/05/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/10/2018 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| 08/02/2017 | BOSTON SCIENTIFIC CORPORATION | GENERAL - THERAPIES (Device) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: THERAPIES | ||||||
| 07/21/2017 | PFIZER PHARMACEUTICALS LLC | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/18/2017 | Allergan Inc. | BOTOX NEURO REHAB (Drug) | Food and Beverage | In-kind items and services | $103.60 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 11 | 17 | $2,975 | $1,515 |
| 2022 | 1 | 14 | 18 | $3,150 | $1,503 |
| 2021 | 1 | 24 | 24 | $5,325 | $2,800 |
| 2020 | 1 | 12 | 12 | $2,395 | $1,475 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 17 | $2,975 | $1,515 | 50.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 18 | $3,150 | $1,503 | 47.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $5,325 | $2,800 | 52.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $2,395 | $1,475 | 61.6% |
About Odrick Rosas, M.D., PH.D
Odrick Rosas, M.D., PH.D is a Physical Medicine & Rehabilitation healthcare provider based in Toa Alta, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/15/2015. The National Provider Identifier (NPI) number assigned to this provider is 1477940500.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Odrick Rosas, M.D., PH.D has received a total of $1,553 in payments from pharmaceutical and medical device companies, with $124.99 received in 2023. These payments were reported across 23 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,553).
As a Medicare-enrolled provider, Rosas has provided services to 61 Medicare beneficiaries, totaling 71 services with total Medicare billing of $7,293. Data is available for 4 years (2020–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Toa Alta, PR
- Active Since 04/15/2015
- Last Updated 05/19/2020
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477940500
Products in Payments
- XARELTO (Drug) $250.00
- FARXIGA (Drug) $248.02
- TOUJEO (Drug) $200.00
- ELIQUIS (Drug) $128.86
- EUFLEXXA (Device) $125.00
- INVOKANA (Drug) $119.99
- BOTOX NEURO REHAB (Drug) $103.60
- Radicava (Drug) $95.65
- STEGLATRO (Drug) $77.91
- LYRICA (Drug) $41.26
- EMFLAZA (Drug) $28.10
- INVOKAMET (Drug) $19.51
- BOTOX (Biological) $18.33
- GENERAL - THERAPIES (Device) $13.89
- Synthroid (Drug) $11.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.